Hedge Funder Eli Casdin Is Loading up on GeneDx Shares

Brendan Coffey, The Motley Fool

Thu, June 11, 2026 astatine 10:01 AM CDT 4 min read

Noted capitalist and GeneDx committee subordinate Eli Casdin has his hedge fund, Casdin Capital, buying up shares of GeneDx Holdings (NASDAQ:WGS).
In the archetypal fewer days of June, Casdin Capital bought 200,000 shares for astir $11.1 million, according to a SEC Form 4 filing. The acquisition comes aft buying 500,000 shares successful May for astir $21.5 million, according to filings.

Transaction summary

Transaction worth based connected SEC Form 4 weighted mean acquisition prices reported successful May and June.

Key questions

• What proportionality of Casdin Capital, LLC's holdings was progressive successful this purchase?
  May’s 500,000-share acquisition represented astir 17% of the entity's full holdings astatine the time, with the bulk classified arsenic indirect ownership done money structures. The June purchases correspond astir 6% of Casdin’s holdings entering the month.

• How does the existent transaction comparison successful size to Casdin Capital, LLC's humanities trading activity?
  This is the lone acquisition of this magnitude successful the caller period, aligning with the maximum commercialized size recorded successful the structured history, and capableness information bespeak that anterior higher-volume enactment was imaginable erstwhile larger holdings were available.

• What is the resulting ownership operation post-transaction?
  After the transaction, Eli Casdin holds 20,517 shares straight and 3,859,555 shares indirectly, done Casdin Capital, LLC, with the indirect presumption attributable to the Casdin Partners Master Fund, L.P. and related entities, maintaining a continuing vulnerability to GeneDx Holdings.

Company overview

Company snapshot

• Offers AI-driven wellness quality solutions that leverage the Centrellis level to integrate objective and genomic information for illness and wellness insights.

• Generates gross done data-driven healthcare services and precocious analytics, supporting precision medicine and individualized wellness management.

• Serves healthcare providers, payers, and probe organizations seeking broad genomic and objective information solutions.

GeneDx Holdings operates astatine standard successful the healthcare accusation services sector, focusing connected the intersection of artificial quality and genomic data. The company’s strategy centers connected delivering advanced, science-driven analytics to alteration much precise healthcare outcomes. Its competitory borderline lies successful integrating multidimensional information and applying instrumentality learning to enactment personalized medicine initiatives.